A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: Diagnosis, pathogenesis, and management

Nancy F. Crum, Kari J. Furtek, Patrick E. Olson, Christopher Amling, Mark R. Wallace

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Hypogonadism and erectile dysfunction (ED) appear to be more common among men infected with HIV compared to age-matched men within the general U.S. population. HIV providers should consider these conditions and utilize standardized evaluation and diagnostic criteria. Treatment of both hypogonadism and ED increases sexual function and quality of life; testosterone supplementation in the setting of hypogonadism may also improve lean body mass, mental status, and anemia. We review the epidemiology, diagnosis, pathogenesis, and treatment options of both hypogonadism and ED among HIV-infected men.

Original languageEnglish (US)
Pages (from-to)655-671
Number of pages17
JournalAIDS Patient Care and STDs
Volume19
Issue number10
DOIs
StatePublished - Oct 2005
Externally publishedYes

Fingerprint

Hypogonadism
Highly Active Antiretroviral Therapy
Erectile Dysfunction
HIV
Testosterone
Anemia
Epidemiology
Quality of Life
Therapeutics
Population

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Leadership and Management
  • Nursing(all)

Cite this

A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras : Diagnosis, pathogenesis, and management. / Crum, Nancy F.; Furtek, Kari J.; Olson, Patrick E.; Amling, Christopher; Wallace, Mark R.

In: AIDS Patient Care and STDs, Vol. 19, No. 10, 10.2005, p. 655-671.

Research output: Contribution to journalArticle

@article{99ff08d899e44f859c5226e02a47bf23,
title = "A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: Diagnosis, pathogenesis, and management",
abstract = "Hypogonadism and erectile dysfunction (ED) appear to be more common among men infected with HIV compared to age-matched men within the general U.S. population. HIV providers should consider these conditions and utilize standardized evaluation and diagnostic criteria. Treatment of both hypogonadism and ED increases sexual function and quality of life; testosterone supplementation in the setting of hypogonadism may also improve lean body mass, mental status, and anemia. We review the epidemiology, diagnosis, pathogenesis, and treatment options of both hypogonadism and ED among HIV-infected men.",
author = "Crum, {Nancy F.} and Furtek, {Kari J.} and Olson, {Patrick E.} and Christopher Amling and Wallace, {Mark R.}",
year = "2005",
month = "10",
doi = "10.1089/apc.2005.19.655",
language = "English (US)",
volume = "19",
pages = "655--671",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras

T2 - Diagnosis, pathogenesis, and management

AU - Crum, Nancy F.

AU - Furtek, Kari J.

AU - Olson, Patrick E.

AU - Amling, Christopher

AU - Wallace, Mark R.

PY - 2005/10

Y1 - 2005/10

N2 - Hypogonadism and erectile dysfunction (ED) appear to be more common among men infected with HIV compared to age-matched men within the general U.S. population. HIV providers should consider these conditions and utilize standardized evaluation and diagnostic criteria. Treatment of both hypogonadism and ED increases sexual function and quality of life; testosterone supplementation in the setting of hypogonadism may also improve lean body mass, mental status, and anemia. We review the epidemiology, diagnosis, pathogenesis, and treatment options of both hypogonadism and ED among HIV-infected men.

AB - Hypogonadism and erectile dysfunction (ED) appear to be more common among men infected with HIV compared to age-matched men within the general U.S. population. HIV providers should consider these conditions and utilize standardized evaluation and diagnostic criteria. Treatment of both hypogonadism and ED increases sexual function and quality of life; testosterone supplementation in the setting of hypogonadism may also improve lean body mass, mental status, and anemia. We review the epidemiology, diagnosis, pathogenesis, and treatment options of both hypogonadism and ED among HIV-infected men.

UR - http://www.scopus.com/inward/record.url?scp=27344445189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27344445189&partnerID=8YFLogxK

U2 - 10.1089/apc.2005.19.655

DO - 10.1089/apc.2005.19.655

M3 - Article

C2 - 16232050

AN - SCOPUS:27344445189

VL - 19

SP - 655

EP - 671

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 10

ER -